Extracorporeal membrane oxygenation (ECMO) essentially acts like an artificial lung or heart. The technology is used when all other forms of heart and lung support have failed for critically ill patients.Now, the treatment is being used to support critically ill patients with COVID-19 pneumonia for whom ventilation is insufficient to sustain blood oxygen levels.55% of COVID-19 patients who had been placed on ECMO had subsequently survived the condition.Today, MGM Healthcare is one of India’s leading ECMO centres, led by a team of intensivists, perfusionists and trained nurses, matching international standards.